Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPR-HRQL Questionnaire Validation with Omeprazole
NCT00641264Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- May 2001
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of omeprazole in laryngopharyngeal reflux (LPR), sponsored by AstraZeneca. Started May 2001; status: completed.
02
Drugs
omeprazole
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on NCT00641264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641264.